Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
CrossRef Glucagon-like peptide-1 receptor agonists in the treatment of non-alcoholic (metabolic-associated) fatty liver disease: a review Svetlana V
Documentation clarity reduces ambiguity before procurement review
The results showed that 4-OI significantly inhibited Erastin-induced BMSCs ferroptosis by activating the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, reduced reactive oxygen species levels and oxidative damage, and restored antioxidant capacity
Gokhale A, Hartwig C, Freeman AA, Bassell JL, Zlatic SA, Savas CS, et al
US$ 26.05
US$ 29.48
US$ 26.23
